Cibc Bancorp Usa Inc. Biocryst Pharmaceuticals Inc Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 22,330 shares of BCRX stock, worth $161,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,330Holding current value
$161,445% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
314Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA21.8MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$144 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$61.5 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$61.2 Million9.06% of portfolio
-
Ubs Group Ag5.97MShares$43.1 Million0.01% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.34B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...